AI assistant
BIO-TECHNE Corp — Director's Dealing 2024
Aug 2, 2024
30718_dirs_2024-08-02_a0a240c5-8392-46f1-b940-06b24afbaa7d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2024-07-31
Reporting Person: Kelderman Kim (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-07-31 | Common Stock | M | 14000 | $37.70 | Acquired | 49421 | Direct |
| 2024-07-31 | Common Stock | F | 9479 | $81.97 | Disposed | 39942 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-07-31 | Stock Option (Right to Buy) | $37.70 | M | 14000 | Disposed | 2025-05-01 | Common Stock (14000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $44.33 | 2025-08-08 | Common Stock (84308) | 84308 | Direct |
| Stock Option (Right to Buy) | $47.60 | 2026-08-07 | Common Stock (109536) | 109536 | Direct |
| Stock Option (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (69264) | 69264 | Direct |
| Stock Option (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (47952) | 47952 | Direct |
| Stock Option (Right to Buy) | $120.46 | 2028-08-06 | Common Stock (25944) | 25944 | Direct |
| Restricted Stock Units | $ | Common Stock (6984) | 6984 | Direct | |
| Performance Stock Option | $94.52 | 2029-08-15 | Common Stock (21704) | 21704 | Direct |
| Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (28940) | 28940 | Direct |
| Restricted Stock Units | $ | Common Stock (8873) | 8873 | Direct | |
| Performance Stock Option | $84.61 | 2030-08-15 | Common Stock (23881) | 23881 | Direct |
| Stock Options (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (29391) | 29391 | Direct |
| Stock Options (Right to Buy) | $52.83 | 2030-11-01 | Common Stock (38252) | 38252 | Direct |
| Restricted Stock Units | $ | Common Stock (9423) | 9423 | Direct | |
| Performance Stock Options (Right to Buy) | $68.54 | 2031-02-01 | Common Stock (25945) | 25945 | Direct |
| Stock Options (Right to Buy) | $68.54 | 2031-02-01 | Common Stock (51890) | 51890 | Direct |
Footnotes
F1: Fully exercisable.
F2: Options to purchase 11,988 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
F3: Options to purchase 6,484 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 6,488 shares vest on each of 8/6/2024 and 8/6/2025.
F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F5: Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6: Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.
F7: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8: Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
F9: Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
F10: Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.